The Association of Clinical Research Organizations (ACRO) is celebrating 20 years since its inception. Doug Peddicord, Ph.D., Executive Director of ACRO, joins us to share his thoughts on some of the biggest changes in clinical research over the last two decades and how they have worked with SCRS through the years. Learn more about ACRO's session at the Global Site Solutions Summit and what role the site voice has in ACRO's important work.

Medidata recently hosted a Site Advocacy Group (SAG) where SCRS member sites offered feedback on budgeting and payments for clinical trials. Tina Mincher, Director, Client Strategy, Clinical Trial Financial Management at Medidata and Edward Czerwinski, Senior Medical Director, FutureMeds, join us to discuss what was learned from a service provider and site perspective. Hear some of the top financial struggles for sites and how sites and industry partners can work together for better transparency with trial budgets and payments.

Amanda Wright​, Chief Development Officer at Javara, a new SCRS Global Impact Partner, shares insights about integrated research organizations (IROs), clinical research as a care option, and how industry partnerships can streamline clinical trials. Learn what initiatives Javara is working on and why joining SCRS was a priority for their organization.

SCRS is excited to welcome Transformative Pharmaceutical Solutions (TPS) to the Global Impact Partner program! Jeff Repper, Executive Vice President, and Kyle Given, EVP, Account Management share why their organization decided to become a GIP and how they want to work with clinical research sites and industry partners to improve the research experience for all.

Technology has the power to reduce the burden on overworked sites–but only if that technology is well-integrated. Catherine Gregor, Chief Clinical Trial Officer at Florence Healthcare, shares insights from her session at the 2022 Global Oncology Site Solutions Summit on challenges and opportunities with site-centric technology. Listen as Catherine shares how sites and Sponsors can ensure they are working together to develop mutually beneficial solutions.

Commemorating a decade since the organization's inception, SCRS spoke with one of our first clinical research site members, Richard Pollack with Evolution Research Group.  Dr. Pollack shines a light on how he was introduced to SCRS and some of his fond memories with the organization while reflecting on how the industry has changed.

Decentralized clinical trial (DCT) technology has the opportunity to create more effective, efficient, and accessible clinical trials. Now that research sites have more experience with these systems, we also have a better understanding of their challenges and opportunities. Craig Lipset, advisor and founder of Clinical Innovation Partners and co-chair of the Decentralized Trials & Research Alliance shares what the clinical trials industry has learned about DCTs and how we can move forward together.

The clinical research industry is currently seeing an unprecedented rise of sites facing financial burden due to increasing costs of staffing and supplies. Now more than ever, it's critical that sites learn what actions they can take to ensure they understand what they are agreeing to in clinical trial agreements and what flexibility they have. Daniel Fox, Ph.D., founder and CEO of the Clinical Research Payment Network,  shares what to look for in CTAs to ensure they are in the site's best interest and how to establish a mutual relationship of trust with industry partners.

SCRS recently held its fourth annual Global Oncology Site Solutions Summit in Austin, Texas. It was an incredible two-day event with actionable insights and best practices specific to oncology clinical research. In this episode, we speak with Peter Fredette, a long-standing member of the SCRS Oncology program and our new Global Oncology Summit chair, to discuss some highlights from this year's conference and what we can expect for the future of the program.

Patient-centricity has been a hot topic in clinical research. Recently the industry has realized that to truly be patient-centric, you must also be site-centric. Deena Bernstein, Vice President of Customer Success at Datacubed, discusses what it means to be site and participant centric in clinical trials and how to reduce the burden of technology for both patients and sites.